CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
2009 ◽
Vol 15
(2)
◽
pp. 104
2014 ◽
Vol 20
(10)
◽
pp. 1516-1521
◽
2008 ◽
Vol 14
(2)
◽
pp. 83
2013 ◽
Vol 19
(2)
◽
pp. S282
2018 ◽
Vol 24
(9)
◽
pp. 1828-1835
◽
2020 ◽
2012 ◽
Vol 40
(11)
◽
pp. 892-898
◽
2007 ◽
Vol 13
(2)
◽
pp. 78-79
2009 ◽
Vol 32
(6)
◽
pp. 618-628
◽